The Deadly Dengue!
•Download as PPT, PDF•
1 like•1,027 views
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. It is transmitted by the Aedes aegypti mosquito and is common in parts of Asia, Africa, and Central and South America. Symptoms include sudden high fever, severe headaches, joint and muscle pain, and skin rash. While there is no vaccine or specific treatment, most people recover after rest. Climate change is causing warmer temperatures that allow mosquitoes to thrive and transmit dengue more easily. Prevention efforts focus on eliminating mosquito breeding habitats and using protective measures like repellents, clothing, and screens.
Report
Share
Report
Share
Recommended
Dengue final pdf
The document summarizes information about dengue fever, including:
1. Dengue fever is caused by the dengue virus and transmitted by Aedes mosquitoes, primarily Aedes aegypti.
2. Aedes aegypti prefers to lay eggs in artificial containers near humans and feeds primarily on people.
3. There are four types of dengue virus; infection with one type usually provides lifelong immunity to that type but only short-term immunity to others, increasing risk of severe illness from a different type in subsequent infections.
Dengue fever
This document provides information on Dengue fever, including:
- It is caused by Dengue viruses 1-4 and transmitted by Aedes mosquitoes. Infection provides lifetime immunity to one serotype but not others.
- Symptoms range from mild fever to severe dengue hemorrhagic fever/dengue shock syndrome. Secondary infections carry higher risk of severe disease.
- Diagnosis involves physical exam, laboratory tests like platelet count and serology. There is no vaccine or antiviral treatment, only supportive care like fluids and fever control. Prevention focuses on mosquito control and avoidance of bites.
Dengue prevention & control
This document discusses dengue prevention and control. It notes that dengue occurs widely in tropical areas and is transmitted by Aedes mosquitoes. Prevention and control requires integrated vector management including larval source reduction through environmental modification, chemical and biological control of immature mosquitoes, and personal protection measures. Disease surveillance and prompt diagnosis/treatment of cases is also important. No vaccine or antiviral currently exists for dengue, so prevention through reducing human-vector contact is key to control.
Dengue
This document provides information about dengue fever, including its causes, symptoms, treatment and prevention. It discusses how dengue fever is caused by infection with one of four dengue virus types transmitted by Aedes mosquitoes. Symptoms include high fever, severe joint pains and characteristic rash. While most cases are mild, some develop into life-threatening dengue hemorrhagic fever or dengue shock syndrome. Treatment focuses on relieving symptoms and fluid replacement to prevent shock. Prevention emphasizes reducing mosquito habitats and limiting exposure to bites.
Dengue Fever
This is my presentation on dengue fever for pharmacy practice-patient counseling
Feel free to like, comment and download.
Dengue fever
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. It is transmitted by Aedes mosquitoes, most commonly A. aegypti. Symptoms include high fever, headache, muscle and joint pains, and a skin rash. In severe cases it can develop into life-threatening dengue hemorrhagic fever or dengue shock syndrome. There is no vaccine, so prevention focuses on controlling mosquito habitats and limiting exposure to bites. Treatment involves fluid replacement and blood transfusion in severe cases.
Dengue Fever
Dengue fever is a prevalent mosquito-borne illness caused by dengue virus and transmitted by Aedes aegypti mosquitoes. It affects over 100 countries and causes 50-100 million infections annually. The disease presentation varies from a nonspecific viral syndrome to severe dengue hemorrhagic fever/dengue shock syndrome. There is no vaccine currently available and treatment involves supportive care, with careful fluid management needed for severe cases to prevent shock. Prevention relies on personal protection from mosquito bites and reducing mosquito breeding sites.
Chikungunya virus
Chikungunya is a mosquito-borne viral disease caused by the Chikungunya virus. It is transmitted via the bites of infected Aedes aegypti and Aedes albopictus mosquitoes. Symptoms include abrupt high fever, joint pains and stiffness. The joint pains often persist for weeks or months in the chronic phase. There is no vaccine and treatment is focused on relieving symptoms. Protection against mosquito bites is the best prevention.
Recommended
Dengue final pdf
The document summarizes information about dengue fever, including:
1. Dengue fever is caused by the dengue virus and transmitted by Aedes mosquitoes, primarily Aedes aegypti.
2. Aedes aegypti prefers to lay eggs in artificial containers near humans and feeds primarily on people.
3. There are four types of dengue virus; infection with one type usually provides lifelong immunity to that type but only short-term immunity to others, increasing risk of severe illness from a different type in subsequent infections.
Dengue fever
This document provides information on Dengue fever, including:
- It is caused by Dengue viruses 1-4 and transmitted by Aedes mosquitoes. Infection provides lifetime immunity to one serotype but not others.
- Symptoms range from mild fever to severe dengue hemorrhagic fever/dengue shock syndrome. Secondary infections carry higher risk of severe disease.
- Diagnosis involves physical exam, laboratory tests like platelet count and serology. There is no vaccine or antiviral treatment, only supportive care like fluids and fever control. Prevention focuses on mosquito control and avoidance of bites.
Dengue prevention & control
This document discusses dengue prevention and control. It notes that dengue occurs widely in tropical areas and is transmitted by Aedes mosquitoes. Prevention and control requires integrated vector management including larval source reduction through environmental modification, chemical and biological control of immature mosquitoes, and personal protection measures. Disease surveillance and prompt diagnosis/treatment of cases is also important. No vaccine or antiviral currently exists for dengue, so prevention through reducing human-vector contact is key to control.
Dengue
This document provides information about dengue fever, including its causes, symptoms, treatment and prevention. It discusses how dengue fever is caused by infection with one of four dengue virus types transmitted by Aedes mosquitoes. Symptoms include high fever, severe joint pains and characteristic rash. While most cases are mild, some develop into life-threatening dengue hemorrhagic fever or dengue shock syndrome. Treatment focuses on relieving symptoms and fluid replacement to prevent shock. Prevention emphasizes reducing mosquito habitats and limiting exposure to bites.
Dengue Fever
This is my presentation on dengue fever for pharmacy practice-patient counseling
Feel free to like, comment and download.
Dengue fever
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. It is transmitted by Aedes mosquitoes, most commonly A. aegypti. Symptoms include high fever, headache, muscle and joint pains, and a skin rash. In severe cases it can develop into life-threatening dengue hemorrhagic fever or dengue shock syndrome. There is no vaccine, so prevention focuses on controlling mosquito habitats and limiting exposure to bites. Treatment involves fluid replacement and blood transfusion in severe cases.
Dengue Fever
Dengue fever is a prevalent mosquito-borne illness caused by dengue virus and transmitted by Aedes aegypti mosquitoes. It affects over 100 countries and causes 50-100 million infections annually. The disease presentation varies from a nonspecific viral syndrome to severe dengue hemorrhagic fever/dengue shock syndrome. There is no vaccine currently available and treatment involves supportive care, with careful fluid management needed for severe cases to prevent shock. Prevention relies on personal protection from mosquito bites and reducing mosquito breeding sites.
Chikungunya virus
Chikungunya is a mosquito-borne viral disease caused by the Chikungunya virus. It is transmitted via the bites of infected Aedes aegypti and Aedes albopictus mosquitoes. Symptoms include abrupt high fever, joint pains and stiffness. The joint pains often persist for weeks or months in the chronic phase. There is no vaccine and treatment is focused on relieving symptoms. Protection against mosquito bites is the best prevention.
Yellow fever
Yellow fever is caused by a flavivirus transmitted by Aedes aegypti mosquitoes. It occurs in tropical areas of Africa and South America, putting over 900 million people at risk. Each year there are approximately 200,000 cases and 30,000 deaths worldwide. The virus is maintained in non-human primates, and humans can be infected either through forest exposure or urban cycles involving humans and mosquitoes. Prevention focuses on vaccination and mosquito control to limit transmission between humans and mosquitoes.
Chikungunya
Chikungunya is an epidemic disease, broke out in Bangladesh in 2017. It was first identified in Tanzania 1953. From then it continuously rose as an epidemic disease after some interval in Asia, Africa and even in America.
Dengue Fever
Dengue (pronounced DENG-gay) can affect anyone but tends to be more severe in people with compromised immune systems. Because it is caused by one of four serotypes of virus, it is possible to get dengue fever multiple times. However, an attack of dengue produces immunity for a lifetime to that particular serotype to which the patient was exposed.
Acute respiratory infections
This document discusses acute respiratory infections (ARI), including their causes, transmission, clinical assessment, classification, treatment, and prevention. It describes the different bacterial and viral agents that can cause ARIs. Clinical assessment involves examining symptoms, breathing rate, chest indrawing, wheezing, and malnutrition. ARIs are classified based on severity and treated with antibiotics or symptomatic care. Prevention focuses on improved living conditions, nutrition, immunization including measles vaccine, Hib vaccine, and pneumococcal pneumonia vaccine.
Dengue
This document summarizes information about dengue, a mosquito-borne viral infection. It discusses the global incidence and distribution of dengue, noting that incidence has increased in recent decades. Dengue symptoms and the different forms it can take are described. Treatment involves symptom relief and fluid maintenance. Vaccines have been developed but have limitations. Prevention relies on controlling mosquito populations and limiting their habitats. Global and national strategies aim to reduce dengue burden through prevention, control programs, and surveillance.
DENGUE FEVER.pptx
Dengue fever is a mosquito-borne viral disease that has rapidly spread worldwide. In Nepal, dengue is endemic and cases have increased in recent years. Between January and September 2022, over 28,000 suspected and confirmed dengue cases and 38 deaths were reported in Nepal, affecting all seven provinces. Dengue virus has four serotypes and infection provides long-term immunity to one serotype but not others, increasing risk for severe dengue from sequential infections. The disease is transmitted by Aedes aegypti mosquitoes and has a 2-7 day viremic phase in humans. Symptoms include an acute flu-like illness that progresses through febrile, critical and recovery phases, with potential for severe
Swine flu
This document discusses H1N1 influenza, also known as swine flu. It provides information on:
- The 2009 H1N1 pandemic which was declared by the WHO.
- Symptoms, transmission, treatment and prevention of H1N1 influenza. Key points are that it is highly contagious and spreads through coughing/sneezing. Oseltamivir is an effective antiviral treatment.
- Those at higher risk include children, pregnant women, elderly, and those with underlying health conditions. Complications can include pneumonia. Vaccination is the best prevention.
EBOLA VIRUS
This document summarizes a seminar presentation on Ebola virus disease (EVD). It provides an overview of EVD outbreaks, case definitions, epidemiology, clinical presentation, diagnosis, treatment, and control/prevention. Key points include: EVD is caused by infection with Ebola virus and transmitted through contact with infected body fluids; symptoms range from fever and fatigue to vomiting and hemorrhaging; diagnosis involves virus detection through antigen/antibody tests or PCR; treatment is supportive care as no vaccine currently exists; control relies on isolation, contact tracing, and barrier precautions.
Yellow fever
This document discusses yellow fever, a viral hemorrhagic disease transmitted by Aedes mosquitoes. It is caused by a flavivirus that primarily affects monkeys but can infect humans. The disease causes liver and kidney damage that can lead to jaundice, hemorrhaging, and death in 20-50% of cases. It is found in tropical areas of Africa and South America. Prevention relies on vaccination and controlling the Aedes aegypti mosquito vector through environmental management and insecticides.
HELMINTHIASIS HELMINTHIC INFECTION
Helminthiasis is caused by parasitic worms called helminths. There are three main groups of helminths that cause disease in humans: nematodes (roundworms), trematodes (flukes), and cestodes (tapeworms). Helminths enter the body through ingestion, arthropod bites, or skin penetration. They can cause intestinal diseases as well as diseases in other organs. Symptoms depend on the specific helminth, but may include gastrointestinal issues, skin rashes, lung problems, and liver or kidney damage. Treatment involves anthelminthic drugs while preventing transmission requires improved sanitation and health education.
Dots
Tuberculosis is caused by Mycobacterium tuberculosis and can affect many organ systems. DOTS (Directly Observed Treatment Shortcourse) is a global program that helps cure TB by having a health worker directly observe a patient taking their full course of anti-TB medications to ensure compliance and prevent drug resistance. India has a high burden of TB with an estimated 1.96 million new cases and 330,000 deaths annually. DOTS involves a short intensive phase of treatment under direct observation followed by a continuation phase where the first dose of each week is taken under supervision.
Chicken pox
This document provides information about chickenpox (varicella). It defines chickenpox as a highly contagious disease caused by the varicella-zoster virus, characterized by an itchy rash of small blisters. The document discusses the incubation period, signs and symptoms, diagnosis, medical management including antiviral medications and vaccines, nursing care, complications, and prevention of chickenpox.
Japanese Encephalitis
Japanese encephalitis is a mosquito-borne viral infection that causes inflammation of the brain. It is most common in parts of Asia including Japan, China, and India. The virus is transmitted via Culex mosquitoes and pigs and birds can act as reservoirs. Most cases occur in children under 15 years of age during the rainy season. Symptoms progress through prodromal, acute encephalitic, and late stages with high fever, seizures, unconsciousness, and potential long-term neurological impairment. Diagnosis involves detecting IgM antibodies or antigens in blood or CSF. Prevention focuses on vaccination programs and vector control like insecticides and larvivorous fish. Treatment involves fever control, anti-convulsants, and
Dengue fever presentation
presentation on mode of transmission, dengue stages, clinical symptoms and laboratory diagnostic of dengue
Dengue ppt
Dengue is a viral disease transmitted by the Aedes aegypti mosquito. It causes flu-like symptoms and in some cases develops into severe dengue or dengue hemorrhagic fever. There are four types of dengue virus. It is endemic in over 100 countries in Asia, Africa, and Latin America. There is no vaccine available and management focuses on treatment of symptoms. Prevention involves reducing mosquito breeding sites and using repellents and nets.
Dengue fever
This document provides information about Dengue fever, including:
1) It describes Dengue fever as the most rapidly spreading mosquito-borne viral disease in the world, caused by the Dengue virus which has 4 serotypes.
2) Symptoms and classifications of Dengue fever are discussed according to the WHO, including dengue fever without hemorrhage, dengue hemorrhagic fever, and dengue shock syndrome.
3) Diagnosis, treatment, prevention and control of Dengue fever and its vectors are summarized, highlighting supportive care, intravenous fluids, monitoring for complications, and the importance of vector control measures.
Cholera - Epidemiology and Prevention
Epidemiology of cholera, its history and clinical features are described. The prevention of cholera has also been discussed. Global roadmap for ending cholera by 2030 is also briefly touched upon. This would be useful for medical students.
Prevention and control of dengue fever
This document discusses dengue fever, its historical background, magnitude as a global public health problem, causative agent, vector, transmission cycle, clinical manifestations, and strategies for prevention and control. It notes that dengue is caused by a virus transmitted by mosquitoes and affects up to 3 billion people globally each year. Prevention focuses on eliminating mosquito breeding sites and reducing human-vector contact through measures like draining standing water and using repellents and nets.
Dengue fever
This document summarizes information about dengue fever, including its epidemiology, virology, clinical manifestations, diagnosis and classification. Some key points:
- Dengue is caused by one of four dengue virus serotypes and is transmitted by Aedes mosquitoes. It is a major public health problem globally and in India.
- Clinical stages include a febrile phase with symptoms like headache and rash, a critical phase with potential for plasma leakage, and a convalescent phase. More severe classifications include dengue hemorrhagic fever and dengue shock syndrome.
- Diagnosis involves tests for dengue NS1 antigen during the acute phase, IgM antibodies later in infection, and
Dengue fever
Dengue fever is an infectious tropical disease caused by the dengue virus and transmitted by mosquitoes. It causes high fever, headache, muscle and joint pains, and a rash. In some cases, it can progress to dengue hemorrhagic fever or dengue shock syndrome, which can be life-threatening. There is no approved vaccine, so prevention focuses on controlling mosquito populations and avoiding bites.
Dengue fever overview 2013
Dengue fever is a common arboviral illness transmitted by mosquitoes of the genus Aedes that infects 50-100 million people annually. It is caused by one of four dengue virus serotypes and presents as a non-specific febrile illness but can also cause classic dengue fever with severe joint pain or the potentially lethal dengue hemorrhagic fever. Diagnosis involves blood tests to detect virus, IgM and IgG antibodies. There is no vaccine and treatment focuses on relieving symptoms and fluid replacement. Prevention emphasizes eliminating mosquito vectors and using repellents and protective clothing.
Dengue fever- clinical features,investigations, diagnosis, treatment and prev...
This presentation is for medical students and general practitioner It contains detailed account of epidemiology, causation, clinical features, investigations,diagnosis, treatment of dengue fever. contains pictures. useful latest and comprehensive information about Dengue. It also contains dengue case definitions of WHO.It also lists the complications of dengue. It enumerates the warning signs for more severe form of dengue fever. Includes risk factors for dengue shock syndrome and dengue hemorrhagic fever.It includes a list if clinical markers of dengue. Also details about the habits of the dengue vector , aedes aegypti mosquito
More Related Content
What's hot
Yellow fever
Yellow fever is caused by a flavivirus transmitted by Aedes aegypti mosquitoes. It occurs in tropical areas of Africa and South America, putting over 900 million people at risk. Each year there are approximately 200,000 cases and 30,000 deaths worldwide. The virus is maintained in non-human primates, and humans can be infected either through forest exposure or urban cycles involving humans and mosquitoes. Prevention focuses on vaccination and mosquito control to limit transmission between humans and mosquitoes.
Chikungunya
Chikungunya is an epidemic disease, broke out in Bangladesh in 2017. It was first identified in Tanzania 1953. From then it continuously rose as an epidemic disease after some interval in Asia, Africa and even in America.
Dengue Fever
Dengue (pronounced DENG-gay) can affect anyone but tends to be more severe in people with compromised immune systems. Because it is caused by one of four serotypes of virus, it is possible to get dengue fever multiple times. However, an attack of dengue produces immunity for a lifetime to that particular serotype to which the patient was exposed.
Acute respiratory infections
This document discusses acute respiratory infections (ARI), including their causes, transmission, clinical assessment, classification, treatment, and prevention. It describes the different bacterial and viral agents that can cause ARIs. Clinical assessment involves examining symptoms, breathing rate, chest indrawing, wheezing, and malnutrition. ARIs are classified based on severity and treated with antibiotics or symptomatic care. Prevention focuses on improved living conditions, nutrition, immunization including measles vaccine, Hib vaccine, and pneumococcal pneumonia vaccine.
Dengue
This document summarizes information about dengue, a mosquito-borne viral infection. It discusses the global incidence and distribution of dengue, noting that incidence has increased in recent decades. Dengue symptoms and the different forms it can take are described. Treatment involves symptom relief and fluid maintenance. Vaccines have been developed but have limitations. Prevention relies on controlling mosquito populations and limiting their habitats. Global and national strategies aim to reduce dengue burden through prevention, control programs, and surveillance.
DENGUE FEVER.pptx
Dengue fever is a mosquito-borne viral disease that has rapidly spread worldwide. In Nepal, dengue is endemic and cases have increased in recent years. Between January and September 2022, over 28,000 suspected and confirmed dengue cases and 38 deaths were reported in Nepal, affecting all seven provinces. Dengue virus has four serotypes and infection provides long-term immunity to one serotype but not others, increasing risk for severe dengue from sequential infections. The disease is transmitted by Aedes aegypti mosquitoes and has a 2-7 day viremic phase in humans. Symptoms include an acute flu-like illness that progresses through febrile, critical and recovery phases, with potential for severe
Swine flu
This document discusses H1N1 influenza, also known as swine flu. It provides information on:
- The 2009 H1N1 pandemic which was declared by the WHO.
- Symptoms, transmission, treatment and prevention of H1N1 influenza. Key points are that it is highly contagious and spreads through coughing/sneezing. Oseltamivir is an effective antiviral treatment.
- Those at higher risk include children, pregnant women, elderly, and those with underlying health conditions. Complications can include pneumonia. Vaccination is the best prevention.
EBOLA VIRUS
This document summarizes a seminar presentation on Ebola virus disease (EVD). It provides an overview of EVD outbreaks, case definitions, epidemiology, clinical presentation, diagnosis, treatment, and control/prevention. Key points include: EVD is caused by infection with Ebola virus and transmitted through contact with infected body fluids; symptoms range from fever and fatigue to vomiting and hemorrhaging; diagnosis involves virus detection through antigen/antibody tests or PCR; treatment is supportive care as no vaccine currently exists; control relies on isolation, contact tracing, and barrier precautions.
Yellow fever
This document discusses yellow fever, a viral hemorrhagic disease transmitted by Aedes mosquitoes. It is caused by a flavivirus that primarily affects monkeys but can infect humans. The disease causes liver and kidney damage that can lead to jaundice, hemorrhaging, and death in 20-50% of cases. It is found in tropical areas of Africa and South America. Prevention relies on vaccination and controlling the Aedes aegypti mosquito vector through environmental management and insecticides.
HELMINTHIASIS HELMINTHIC INFECTION
Helminthiasis is caused by parasitic worms called helminths. There are three main groups of helminths that cause disease in humans: nematodes (roundworms), trematodes (flukes), and cestodes (tapeworms). Helminths enter the body through ingestion, arthropod bites, or skin penetration. They can cause intestinal diseases as well as diseases in other organs. Symptoms depend on the specific helminth, but may include gastrointestinal issues, skin rashes, lung problems, and liver or kidney damage. Treatment involves anthelminthic drugs while preventing transmission requires improved sanitation and health education.
Dots
Tuberculosis is caused by Mycobacterium tuberculosis and can affect many organ systems. DOTS (Directly Observed Treatment Shortcourse) is a global program that helps cure TB by having a health worker directly observe a patient taking their full course of anti-TB medications to ensure compliance and prevent drug resistance. India has a high burden of TB with an estimated 1.96 million new cases and 330,000 deaths annually. DOTS involves a short intensive phase of treatment under direct observation followed by a continuation phase where the first dose of each week is taken under supervision.
Chicken pox
This document provides information about chickenpox (varicella). It defines chickenpox as a highly contagious disease caused by the varicella-zoster virus, characterized by an itchy rash of small blisters. The document discusses the incubation period, signs and symptoms, diagnosis, medical management including antiviral medications and vaccines, nursing care, complications, and prevention of chickenpox.
Japanese Encephalitis
Japanese encephalitis is a mosquito-borne viral infection that causes inflammation of the brain. It is most common in parts of Asia including Japan, China, and India. The virus is transmitted via Culex mosquitoes and pigs and birds can act as reservoirs. Most cases occur in children under 15 years of age during the rainy season. Symptoms progress through prodromal, acute encephalitic, and late stages with high fever, seizures, unconsciousness, and potential long-term neurological impairment. Diagnosis involves detecting IgM antibodies or antigens in blood or CSF. Prevention focuses on vaccination programs and vector control like insecticides and larvivorous fish. Treatment involves fever control, anti-convulsants, and
Dengue fever presentation
presentation on mode of transmission, dengue stages, clinical symptoms and laboratory diagnostic of dengue
Dengue ppt
Dengue is a viral disease transmitted by the Aedes aegypti mosquito. It causes flu-like symptoms and in some cases develops into severe dengue or dengue hemorrhagic fever. There are four types of dengue virus. It is endemic in over 100 countries in Asia, Africa, and Latin America. There is no vaccine available and management focuses on treatment of symptoms. Prevention involves reducing mosquito breeding sites and using repellents and nets.
Dengue fever
This document provides information about Dengue fever, including:
1) It describes Dengue fever as the most rapidly spreading mosquito-borne viral disease in the world, caused by the Dengue virus which has 4 serotypes.
2) Symptoms and classifications of Dengue fever are discussed according to the WHO, including dengue fever without hemorrhage, dengue hemorrhagic fever, and dengue shock syndrome.
3) Diagnosis, treatment, prevention and control of Dengue fever and its vectors are summarized, highlighting supportive care, intravenous fluids, monitoring for complications, and the importance of vector control measures.
Cholera - Epidemiology and Prevention
Epidemiology of cholera, its history and clinical features are described. The prevention of cholera has also been discussed. Global roadmap for ending cholera by 2030 is also briefly touched upon. This would be useful for medical students.
Prevention and control of dengue fever
This document discusses dengue fever, its historical background, magnitude as a global public health problem, causative agent, vector, transmission cycle, clinical manifestations, and strategies for prevention and control. It notes that dengue is caused by a virus transmitted by mosquitoes and affects up to 3 billion people globally each year. Prevention focuses on eliminating mosquito breeding sites and reducing human-vector contact through measures like draining standing water and using repellents and nets.
Dengue fever
This document summarizes information about dengue fever, including its epidemiology, virology, clinical manifestations, diagnosis and classification. Some key points:
- Dengue is caused by one of four dengue virus serotypes and is transmitted by Aedes mosquitoes. It is a major public health problem globally and in India.
- Clinical stages include a febrile phase with symptoms like headache and rash, a critical phase with potential for plasma leakage, and a convalescent phase. More severe classifications include dengue hemorrhagic fever and dengue shock syndrome.
- Diagnosis involves tests for dengue NS1 antigen during the acute phase, IgM antibodies later in infection, and
Dengue fever
Dengue fever is an infectious tropical disease caused by the dengue virus and transmitted by mosquitoes. It causes high fever, headache, muscle and joint pains, and a rash. In some cases, it can progress to dengue hemorrhagic fever or dengue shock syndrome, which can be life-threatening. There is no approved vaccine, so prevention focuses on controlling mosquito populations and avoiding bites.
What's hot (20)
Viewers also liked
Dengue fever overview 2013
Dengue fever is a common arboviral illness transmitted by mosquitoes of the genus Aedes that infects 50-100 million people annually. It is caused by one of four dengue virus serotypes and presents as a non-specific febrile illness but can also cause classic dengue fever with severe joint pain or the potentially lethal dengue hemorrhagic fever. Diagnosis involves blood tests to detect virus, IgM and IgG antibodies. There is no vaccine and treatment focuses on relieving symptoms and fluid replacement. Prevention emphasizes eliminating mosquito vectors and using repellents and protective clothing.
Dengue fever- clinical features,investigations, diagnosis, treatment and prev...
This presentation is for medical students and general practitioner It contains detailed account of epidemiology, causation, clinical features, investigations,diagnosis, treatment of dengue fever. contains pictures. useful latest and comprehensive information about Dengue. It also contains dengue case definitions of WHO.It also lists the complications of dengue. It enumerates the warning signs for more severe form of dengue fever. Includes risk factors for dengue shock syndrome and dengue hemorrhagic fever.It includes a list if clinical markers of dengue. Also details about the habits of the dengue vector , aedes aegypti mosquito
Dengue
Dr. Sachin Verma is a young, diligent and dynamic physician. He did his graduation from IGMC Shimla and MD in Internal Medicine from GSVM Medical College Kanpur. Then he did his Fellowship in Intensive Care Medicine (FICM) from Apollo Hospital Delhi. He has done fellowship in infectious diseases by Infectious Disease Society of America (IDSA). He has also done FCCS course and is certified Advance Cardiac Life support (ACLS) and Basic Life Support (BLS) provider by American Heart Association. He has also done a course in Cardiology by American College of Cardiology and a course in Diabetology by International Diabetes Centre. He specializes in the management of Infections, Multiorgan Dysfunctions and Critically ill patients and has many publications and presentations in various national conferences under his belt. He is currently working in NABH Approved Ivy super-specialty Hospital Mohali as Consultant Intensivists and Physician.
Dengue fever slide
Dengue fever is a disease caused by viruses transmitted by mosquitoes. Symptoms include headache, fever, joint pain, and rash. It can range from mild to life-threatening hemorrhagic fever. While prevalent in tropical areas, local transmission has occurred in Florida. There is no vaccine or specific treatment, so prevention depends on controlling the mosquito population.
Dengue fever
Dengue fever is caused by the dengue virus, which is transmitted by the Aedes aegypti mosquito. It has four distinct serotypes. The virus replicates in the mosquito and humans, who serve as the primary reservoir of infection. Symptoms range from a mild fever to the potentially lethal dengue hemorrhagic fever. There is no vaccine, so prevention depends on controlling the mosquito population and avoiding bites.
DENGUE FEVER
1) Dengue fever is caused by mosquitoes of the genus Aedes, mainly A. aegypti, and is prevalent during rainy seasons when mosquito populations increase. Improper waste disposal also contributes to mosquito propagation.
2) Dengue virus consists of 4 serotypes that cause disease in humans. Major epidemics have occurred across Asia and there have been recent outbreaks in Pakistan.
3) Clinical presentation ranges from mild dengue fever to severe dengue hemorrhagic fever/dengue shock syndrome. Outpatient management is usually sufficient but hospitalization may be needed for dehydration, bleeding, or low platelet count. Prevention relies on environmental controls and public education.
The dengue virus structure
A presentation on dengue virus structure, how the virus attacks and spreads in the body, role of heterocyclic drugs in inhibiting the virus and our experiments on the subject.
Dengue fever
1. The document provides guidelines for diagnosing and treating dengue fever, which is caused by the dengue virus and transmitted by Aedes aegypti mosquitoes.
2. It outlines the typical phases of dengue illness - febrile, critical, and recovery phase - and describes the clinical manifestations at each stage.
3. Patients are classified into groups - A, B, or C - depending on severity of symptoms and need for home care versus hospital admission and management. Close monitoring is important to watch for warning signs and progression to more severe disease.
Dangue - If they breed, you will bleed.
Dengue is a mosquito-borne viral disease transmitted by Aedes mosquitoes that can cause flu-like symptoms including fever, rash and joint pain. It is a major public health challenge in tropical and subtropical regions of the world with around 50 million cases estimated each year. The document outlines the causative virus, transmission, clinical features and management of dengue as well as prevention strategies focusing on mosquito control and community education.
6. Dengue Fever
Dengue fever is an acute febrile illness caused by the dengue virus and transmitted by Aedes mosquitoes. It is manifested by fever, bleeding, muscle and joint pains. There is no vaccine currently available. It is diagnosed through tests detecting antibodies or viral RNA. Treatment involves rehydration, antipyretics, platelet transfusions, and close monitoring. Prevention efforts focus on reducing mosquito habitats and populations.
Dengue Fever
Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. It is characterized by fever, headache, muscle and joint pains, and a skin rash. Some cases develop into life-threatening dengue hemorrhagic fever or dengue shock syndrome. It occurs widely in tropical areas and an estimated 50 million infections occur annually. The disease progresses through febrile, critical, and recovery phases. During the critical phase, increased capillary permeability can lead to life-threatening plasma leakage and shock.
Dengue fever final
This document provides information on dengue fever, a mosquito-borne viral infection. It discusses the clinical presentation and pathophysiology of dengue fever and the more severe forms of dengue hemorrhagic fever and dengue shock syndrome. Key points include that dengue fever presents as an acute febrile illness and is caused by one of four related viruses. In rare cases it can progress to dengue hemorrhagic fever or dengue shock syndrome, characterized by bleeding and shock. Treatment involves supportive care and fluid replacement for dehydration.
Understanding dengue
This document provides an overview of dengue fever, including its causes, transmission, global impact, and prevention. Some key points:
- Dengue fever is a viral disease transmitted by Aedes mosquitoes, primarily Aedes aegypti. There are 4 types of dengue viruses.
- It affects over 50 million people annually worldwide and is a major public health challenge in many tropical and subtropical countries, including the Philippines.
- Transmission occurs when an infected mosquito bites a person and transmits the virus. There is typically an incubation period of 4-7 days before symptoms appear.
- Symptoms range from mild fever to severe dengue hemorrhagic fever. Treatment depends on
Dengue
Dengue fever is caused by a virus transmitted by mosquitoes and causes flu-like symptoms such as fever, headache, muscle and joint pain. It occurs in tropical and subtropical regions and there is no vaccine or specific treatment, though symptoms can be relieved with rest, hydration and pain medication. A severe form called dengue hemorrhagic fever can occur in children and cause bleeding, shock and death in some cases. Prevention focuses on controlling mosquito populations and avoiding bites.
Dengue
This document discusses dengue fever, caused by the Aedes mosquito. It notes that dengue illness predominantly affects pediatric populations and can have a high mortality rate. Clinical presentation can vary widely, from fever to bleeding to shock. The disease progresses through febrile, leaky, and congestive phases. Diagnosis involves clinical observation, hematological tests, and virological methods. Management is supportive through monitoring and intervening early if warning signs appear. Prognosis is favorable with early recognition and treatment of plasma leakage and thrombocytopenia. Prevention focuses on eliminating mosquito breeding sites and preventing bites.
Dengue- WS on vector borne viral infection 2011
The document discusses dengue virus and the dengue situation in Sri Lanka. It provides details on dengue virus such as its family, serotypes, laboratory diagnosis methods, pathogenesis, and vaccine candidates. It notes that though all four dengue serotypes are circulating in Sri Lanka, serotypes 2 and 3 were predominant before 1989 when the first dengue hemorrhagic fever outbreak occurred, linked to serotype 3 subtype III group B. Genetic analysis showed the strain associated with dengue hemorrhagic fever had genetic changes compared to earlier serotype 3 strains that caused dengue fever. Surveillance data on circulating serotypes from 2006-2011 is also presented.
Dengue treatment (in sinhala language)
Jayadeva de Silva is a Sri Lankan national who has worked in various roles in the technology industry for over 15 years. He has extensive experience managing teams and delivering projects on time and on budget. Currently, he is seeking new opportunities where he can continue leveraging his leadership skills and track record of success.
Dengue
Dengue is an acute febrile illness caused by one of four serotypes of the dengue virus transmitted by Aedes aegypti mosquitoes. Primary infection causes an IgM antibody response while secondary infection by a different serotype can cause severe dengue due to antibody-dependent enhancement. The disease progresses through three phases - febrile, critical, and recovery. The critical phase is characterized by increased vascular permeability leading to plasma leakage and potential development of shock. Diagnosis involves laboratory tests showing thrombocytopenia and hemoconcentration. Treatment is supportive and focuses on fluid management and antipyresis. Prevention relies on mosquito control and vaccine development.
Dengue fever
This document provides information about dengue fever, including its signs and symptoms, transmission, diagnosis, treatment and prevention. It is presented as a slideshow with sections on the introduction, clinical course, diagnosis, management and prevention of dengue fever. Key points include that dengue fever is caused by the dengue virus and transmitted by mosquitoes, it typically causes fever, joint pains and rash, and diagnosis involves clinical assessment and may include laboratory tests. Treatment focuses on fluid management and prevention depends on controlling mosquito vectors.
Dengue haemorrhagic fever diagnosis & management
This document provides guidance on diagnosing and managing dengue fever (DF) and dengue hemorrhagic fever (DHF). It defines the different phases of dengue infection and outlines criteria for differentiating DF from DHF. Management involves supportive care during the febrile phase and careful fluid management to prevent shock during the critical leakage phase. Common causes of death from dengue include fluid overload, hemorrhage, profound shock, and multi-organ failure. Proper outpatient treatment, monitoring for warning signs, and administering the right amount of fluids or blood transfusions as needed can help prevent dengue deaths.
Viewers also liked (20)
Dengue fever- clinical features,investigations, diagnosis, treatment and prev...
Dengue fever- clinical features,investigations, diagnosis, treatment and prev...
Similar to The Deadly Dengue!
Bejar, malaika
The document discusses dengue fever, which is caused by dengue viruses and transmitted by mosquitoes. It describes the symptoms of mild dengue fever and more severe forms like dengue hemorrhagic fever and dengue shock syndrome. There is no vaccine or specific treatment, so treatment focuses on relieving symptoms and fluid replacement. Controlling mosquito populations through eliminating breeding sites and using repellents and nets is important for prevention.
What are the principal causes of spreading dengue.pdf
Humans get the viral disease dengue (break-bone fever) through mosquitoes. The
majority of dengue patients have no symptoms. However, for those who do, high temperature, headache, body pains, nausea, and rash are the most typical
symptoms.
Dengue disease ppt
Dengue fever is a mosquito-borne viral disease that causes flu-like symptoms including fever, headaches, rashes, and joint pain. It is transmitted to humans through the bites of infected Aedes mosquitoes. There is no vaccine to prevent dengue, but basic protective measures like wearing repellent and covering exposed skin can help avoid infection. Severe dengue is a potentially lethal complication but most cases resolve on their own with rest and hydration. Around 500,000 people require hospitalization for dengue each year in tropical areas worldwide.
Dengue Final.pptx viral infection transmitted to humans through the bite of i...
Dengue is a viral infection transmitted to humans through the bite of infected mosquitoes.
About half of the world's population is now at risk of dengue with an estimated 100–400 million infections occurring each year.
Dengue is found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas.
While many dengue infections are asymptomatic or produce only mild illness, the virus can occasionally cause more severe cases, and even death.
Prevention and control of dengue depend on vector control. There is no specific treatment for dengue/severe dengue, and early detection and access to proper medical care greatly lower fatality rates of severe dengue.Dengue is a viral infection transmitted to humans through the bite of infected mosquitoes.
About half of the world's population is now at risk of dengue with an estimated 100–400 million infections occurring each year.
Dengue is found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas.
While many dengue infections are asymptomatic or produce only mild illness, the virus can occasionally cause more severe cases, and even death.
Prevention and control of dengue depend on vector control. There is no specific treatment for dengue/severe dengue, and early detection and access to proper medical care greatly lower fatality rates of severe dengue.Dengue is a viral infection transmitted to humans through the bite of infected mosquitoes.
About half of the world's population is now at risk of dengue with an estimated 100–400 million infections occurring each year.
Dengue is found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas.
While many dengue infections are asymptomatic or produce only mild illness, the virus can occasionally cause more severe cases, and even death.
Prevention and control of dengue depend on vector control. There is no specific treatment for dengue/severe dengue, and early detection and access to proper medical care greatly lower fatality rates of severe dengue.Dengue is a viral infection transmitted to humans through the bite of infected mosquitoes.
About half of the world's population is now at risk of dengue with an estimated 100–400 million infections occurring each year.
Dengue is found in tropical and sub-tropical climates worldwide, mostly in urban and semi-urban areas.
While many dengue infections are asymptomatic or produce only mild illness, the virus can occasionally cause more severe cases, and even death.
Prevention and control of dengue depend on vector control. There is no specific treatment for dengue/severe dengue, and early detection and access to proper medical care greatly lower fatality rates of severe dengue.Dengue is a viral infection transmitted to humans through the bite of infected mosquitoes.
About half of the world's population is now at risk of dengue with an estimated 100–400 million infections occurring each year.
Dengue is found in tropical and sub-tropical climates
Dengue fever
Dengue fever is a mosquito-borne viral disease caused by any of four dengue viruses and transmitted through the bites of infected Aedes mosquitoes. It is a leading cause of illness and death in tropical and subtropical regions. Symptoms include high fever, severe headaches, joint and muscle pain, nausea and vomiting. There is no vaccine or specific treatment, but maintaining proper fluid balance and rest is important. Prevention focuses on reducing mosquito habitats and using insect repellents and protective clothing when outdoors.
denguefeverthanu-181010063402.pptx
Dengue fever is a mosquito-borne viral disease caused by any of four dengue viruses. It is transmitted by the bite of an infected Aedes mosquito. An estimated 390 million dengue infections occur worldwide each year, especially in tropical areas of Southeast Asia, South America, and the Caribbean. Symptoms include high fever, severe headaches, joint and muscle pain, and skin rash. There is no vaccine to prevent dengue fever, so protection involves preventing mosquito bites by wearing protective clothing and using insect repellent. Treatment focuses on relieving symptoms and maintaining fluid balance, with medical care needed in severe cases to prevent complications like bleeding and shock.
DENGUE
Dengue fever is an illness caused by infection from one of four dengue virus types transmitted by Aedes mosquitoes. It is a major health problem in Pakistan with over 100 million cases worldwide annually. Symptoms include fever, headaches, joint pains and skin rash. There is no vaccine or cure, but early diagnosis and fluid replacement therapy can effectively treat dengue hemorrhagic fever, the more severe form. Prevention relies on eliminating stagnant water sources where mosquitoes breed and using repellents and protective clothing.
Air-borne disease-- Dengue fever disease
This is the ppt on Dengue fever. I have briefly described about the modes of transmission, symptoms, causes and treatment of Dengue.
Dengue- A Killer disease
All of you are well aware about the drastic rise in the number of dengue fever cases reported in Delhi since August this year. It has reached epidemic proportions in the capital and thus it has witnessed the worst outbreak in the past six years.
Dengue Fever_ Causes, Symptoms, Prevention & Treatment.pdf
Dengue fever, caused by the dengue virus, is a significant public health issue in many tropical and subtropical regions worldwide. This blog post will delve into the causes, symptoms, prevention, and treatment of dengue fever, with a focus on essential aspects such as the dengue virus, dengue test, dengue vaccine, dengue platelet count, and the duration of the illness.
For More details : https://blog.simpleekare.com/dengue-fever-causes-symptoms-prevention-treatment/
Week7 assgn2alharp.
Dengue is a mosquito-borne viral disease that causes flu-like symptoms such as fever, headache, muscle and joint pain, and skin rash. While many infected have no symptoms, those who do experience symptoms typically have a sudden onset of fever lasting 3-7 days. There is no specific treatment for dengue fever, but resting and drinking plenty of fluids can help relieve symptoms. A rare, severe form called dengue hemorrhagic fever can be life-threatening and requires urgent treatment. Prevention focuses on eliminating mosquito breeding sites and protecting against mosquito bites with clothing, repellents, and nets.
Football World Cup 2014 Health Advisory from Riskpro
Football World Cup 2014 Health Advisory if you are traveling to South America and Brazil. Original created by my colleagues at Riskpro
About Dengue Fever
The document discusses dengue fever, including that it is caused by four types of dengue virus and transmitted through the bites of infected Aedes mosquitoes. Symptoms of dengue fever include high fever, severe headaches, joint and muscle pain, nausea and vomiting, and rash. More severe cases can involve bleeding, shock, and death. While there is no specific treatment, drinking fluids and rest can help with recovery. Prevention involves avoiding mosquito bites and areas where they breed.
How to Protect Yourself from Dengue fever pdf
Dengue fever is primarily spread through the bite of infected mosquitoes, particularly the Aedes aegypti and, to a lesser extent, Aedes albopictus mosquitoes. Here is an overview of how the transmission of dengue occurs:
Infected Human Host
Viral Replication in Humans
Presence of Virus in Blood Etc
Dengue fever
Dengue fever is a mosquito-borne viral infection that causes flu-like symptoms including high fever, headache, and joint pains. It is transmitted to humans through the bites of infected Aedes aegypti mosquitoes. While most cases are mild, severe dengue can cause bleeding, organ impairment, and death if not treated properly. There is currently no vaccine, so prevention focuses on eliminating mosquito breeding sites and using insect repellent and protective clothing.
11 mosquitoes borne viral diseases
The document discusses four mosquito-borne viral diseases: dengue, Japanese encephalitis, yellow fever, and chikungunya fever. It provides details on the causative viruses, transmission cycles, symptoms, treatment and prevention for each disease. Dengue is the most rapidly spreading mosquito-borne disease and exists throughout the tropics, mainly spread by Aedes aegypti and Aedes albopictus mosquitoes. Japanese encephalitis virus is transmitted in a zoonotic cycle between birds and pigs, with Culex mosquitoes acting as vectors. Yellow fever virus circulates between non-human primates and humans in Africa and South America. Chikungunya virus causes debilitating symptoms
Chikungunia
This document provides information about Chikungunya virus and disease. It discusses that Chikungunya is an infection caused by the Chikungunya virus and transmitted via mosquito bites. It causes fever and severe joint pain. While most people recover within a week, joint pain can sometimes persist for months. The document outlines the virus classification, signs and symptoms, treatment, history, outbreaks and prevention of Chikungunya infection.
CHICUNGUNYA
Chikungunya is a viral disease spread through mosquito bites. It causes fever, rash and severe joint pain. The virus was first identified in Africa in 1952 and there have since been outbreaks in Asia and islands in the Indian Ocean. It is transmitted by Aedes mosquitoes which breed in small, stagnant water sources. There is no vaccine or treatment, so prevention focuses on reducing mosquito habitats and using repellents. Outbreaks require community education and source reduction efforts to eliminate breeding sites and interrupt transmission.
25231
Chikungunya is a viral disease spread through mosquito bites. It causes fever, rash and severe joint pain. The virus was first identified in Africa in 1952. Major outbreaks have occurred in parts of Asia and islands in the Indian Ocean. There is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and protecting against bites. Symptoms are usually self-limiting, but joint pain can persist for months or years.
25231
Chikungunya is a viral disease spread through mosquito bites. It causes fever, rash and severe joint pain. The virus was first identified in Africa in 1952. Major outbreaks have occurred in parts of Asia and islands in the Indian Ocean. There is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and protecting against bites. Symptoms are usually self-limiting, but joint pain can persist for months or years.
Similar to The Deadly Dengue! (20)
What are the principal causes of spreading dengue.pdf
What are the principal causes of spreading dengue.pdf
Dengue Final.pptx viral infection transmitted to humans through the bite of i...
Dengue Final.pptx viral infection transmitted to humans through the bite of i...
Dengue Fever_ Causes, Symptoms, Prevention & Treatment.pdf
Dengue Fever_ Causes, Symptoms, Prevention & Treatment.pdf
Football World Cup 2014 Health Advisory from Riskpro
Football World Cup 2014 Health Advisory from Riskpro
Recently uploaded
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Do you have abnormal smell after periods? It may be vaginitis. Do not worry, herbal medicine Fuyan Pill can help you get a cure.
DECLARATION OF HELSINKI - History and principles
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
Top Travel Vaccinations in Manchester
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
une 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Breast cancer: Post menopausal endocrine therapy
Breast cancer in postmenopausal women with hormone receptor-positive (HR+) status is a common and complex condition that necessitates a multifaceted approach to management. HR+ breast cancer means that the cancer cells grow in response to hormones such as estrogen and progesterone. This subtype is prevalent among postmenopausal women and typically exhibits a more indolent course compared to other forms of breast cancer, which allows for a variety of treatment options.
Diagnosis and Staging
The diagnosis of HR+ breast cancer begins with clinical evaluation, imaging, and biopsy. Imaging modalities such as mammography, ultrasound, and MRI help in assessing the extent of the disease. Histopathological examination and immunohistochemical staining of the biopsy sample confirm the diagnosis and hormone receptor status by identifying the presence of estrogen receptors (ER) and progesterone receptors (PR) on the tumor cells.
Staging involves determining the size of the tumor (T), the involvement of regional lymph nodes (N), and the presence of distant metastasis (M). The American Joint Committee on Cancer (AJCC) staging system is commonly used. Accurate staging is critical as it guides treatment decisions.
Treatment Options
Endocrine Therapy
Endocrine therapy is the cornerstone of treatment for HR+ breast cancer in postmenopausal women. The primary goal is to reduce the levels of estrogen or block its effects on cancer cells. Commonly used agents include:
Selective Estrogen Receptor Modulators (SERMs): Tamoxifen is a SERM that binds to estrogen receptors, blocking estrogen from stimulating breast cancer cells. It is effective but may have side effects such as increased risk of endometrial cancer and thromboembolic events.
Aromatase Inhibitors (AIs): These drugs, including anastrozole, letrozole, and exemestane, lower estrogen levels by inhibiting the aromatase enzyme, which converts androgens to estrogen in peripheral tissues. AIs are generally preferred in postmenopausal women due to their efficacy and safety profile compared to tamoxifen.
Selective Estrogen Receptor Downregulators (SERDs): Fulvestrant is a SERD that degrades estrogen receptors and is used in cases where resistance to other endocrine therapies develops.
Combination Therapies
Combining endocrine therapy with other treatments enhances efficacy. Examples include:
Endocrine Therapy with CDK4/6 Inhibitors: Palbociclib, ribociclib, and abemaciclib are CDK4/6 inhibitors that, when combined with endocrine therapy, significantly improve progression-free survival in advanced HR+ breast cancer.
Endocrine Therapy with mTOR Inhibitors: Everolimus, an mTOR inhibitor, can be added to endocrine therapy for patients who have developed resistance to aromatase inhibitors.
Chemotherapy
Chemotherapy is generally reserved for patients with high-risk features, such as large tumor size, high-grade histology, or extensive lymph node involvement. Regimens often include anthracyclines and taxanes.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Dr. ZANAB FARHEEN FAYAZ ,MDS(ORTHODONTICS & DENTOFACIAL ORTHOPEDICS ).
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Kosmoderma Academy Of Aesthetic Medicine
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
How to choose the best dermatologists in Indore.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
How to Control Your Asthma Tips by gokuldas hospital.
Respiratory issues like asthma are the most sensitive issue that is affecting millions worldwide. It hampers the daily activities leaving the body tired and breathless.
The key to a good grip on asthma is proper knowledge and management strategies. Understanding the patient-specific symptoms and carving out an effective treatment likewise is the best way to keep asthma under control.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Recently uploaded (20)
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
The Deadly Dengue!
- 1. DENGUE FEVER
- 2. INTRODUCTION Dengue fever also known as breakbone fever, is a mosquito-borne tropical disease caused by Dengue virus. It is most common in South East Asia, India, the Caribbean, South and Central America, and Africa. the dengue virus. It is transmitted by Aedes aegypti mosquito.
- 4. SYMPTOMS • Sudden, high fever • Severe headaches • Pain behind the eyes • Severe joint and muscle pain • Nausea • Vomiting • Skin rash, which appears three to four days after the onset of fever • Mild bleeding (such a nose bleed, bleeding gums, or easy bruising)
- 7. Is climate change related to dengue?? Dengue can occur all-round the year, more likely towards the end of rainy season. In the coming years, the number of cases is likely to increase but the fatality would definitely decrease due to medical advancements. Growth of mosquitoes, its development and progress will change due to the climate change.
- 8. These mosquitoes have actually adapted themselves to the climate in such a way that they can breed even in warmer climates. The warmer it becomes, better it is for the mosquitoes. If it becomes cooler automatically it becomes dangerous to the mosquitoes.
- 9. TREATMENT There’s no vaccine against dengue fever, and no specific treatment. Most people recover after a brief illness. We can reduce our chance of getting dengue fever by taking measures to prevent mosquito bites.
- 10. PREVENTIVE METHODS preventing mosquitoes from accessing egg-laying habitats by environmental management and modification; disposing of solid waste properly and removing artificial man-made habitats; covering, emptying and cleaning of domestic water storage containers on a weekly basis; applying appropriate insecticides to water storage outdoor containers;
- 11. using of personal household protection such as window screens, long-sleeved clothes, insecticide treated materials, coils and vaporizers; improving community participation and mobilization for sustained vector control; applying insecticides as space spraying during outbreaks as one of the emergency vector control measures; active monitoring and surveillance of vectors should be carried out to determine effectiveness of control interventions.
- 15. Thank You